Page last updated: 2024-09-05

sb 203580 and cgp 57380

sb 203580 has been researched along with cgp 57380 in 5 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(cgp 57380)
Trials
(cgp 57380)
Recent Studies (post-2010) (cgp 57380)
3,48941,13764044

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)cgp 57380 (IC50)
Serine/threonine-protein kinase Sgk1Homo sapiens (human)2.7
Dual specificity tyrosine-phosphorylation-regulated kinase 3Homo sapiens (human)3.2
Cytochrome P450 1A2Homo sapiens (human)1.6
Proto-oncogene tyrosine-protein kinase LCK Mus musculus (house mouse)2.5
Eukaryotic translation initiation factor 4EHomo sapiens (human)3
Cytochrome P450 2D6Homo sapiens (human)1.6
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)5
Casein kinase I isoform deltaHomo sapiens (human)0.51
Serine/threonine-protein kinase BRSK2Homo sapiens (human)1.1
Aurora kinase BHomo sapiens (human)2.5
MAP kinase-interacting serine/threonine-protein kinase 1Homo sapiens (human)1.2182
MAP kinase-interacting serine/threonine-protein kinase 2Homo sapiens (human)2.06

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1
Morley, SJ; Naegele, S1
Cherla, RP; Lee, SY; Mees, PL; Tesh, VL1
Frost, P; Fukunaga, R; Gera, J; Hoang, B; Lichtenstein, A; Shi, Y; Yang, Y1

Other Studies

5 other study(ies) available for sb 203580 and cgp 57380

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013
Phosphorylation of initiation factor 4E is resistant to SB203580 in cells expressing a drug-resistant mutant of stress-activated protein kinase 2a/p38.
    Cellular signalling, 2003, Volume: 15, Issue:8

    Topics: Aniline Compounds; Arsenites; Cell Line; Chromones; Drug Resistance; Enzyme Inhibitors; Eukaryotic Initiation Factor-4E; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Morpholines; Mutation; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Purines; Pyridines; Signal Transduction; Stress, Physiological

2003
Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line.
    Journal of leukocyte biology, 2006, Volume: 79, Issue:2

    Topics: Aniline Compounds; Anisomycin; Anthracenes; Cell Line, Tumor; Cytokines; Dose-Response Relationship, Drug; Eukaryotic Initiation Factor-4E; Flavonoids; Humans; Imidazoles; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Purines; Pyridines; RNA, Messenger; Shiga Toxin 1; Time Factors

2006
MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.
    Oncogene, 2013, Jan-10, Volume: 32, Issue:2

    Topics: 5' Untranslated Regions; Aniline Compounds; Animals; Butadienes; Cell Line, Tumor; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Genes, myc; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Mice; Multiple Myeloma; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc; Purines; Pyridines; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sirolimus; TOR Serine-Threonine Kinases; Up-Regulation

2013